The Effect of Distant Reiki Application on Pain, Functional Status and Sleep Quality

Sponsor
Aksaray University Training and Research Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05861934
Collaborator
(none)
40
2
2
8
20
2.5

Study Details

Study Description

Brief Summary

Rheumatoid Arthritis (RA) is a chronic, multisystemic, progressive autoimmune disease characterized by joint destruction in synovial tissue, causing joint swelling, pain and morning stiffness. It is estimated to affect 0.1%-2% of the world's adult population and more women than men. RA limits individuals' work, social, and home lives and functional capacities. Patients commonly experience pain and accompanying sleep problems. Interventions for these problems and symptom management are important. In this regard, this study was planned to examine the effect of distant reiki application on pain, functional status and sleep quality in rheumatoid arthritis patients.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Distant reiki group
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
40 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Triple (Participant, Care Provider, Outcomes Assessor)
Primary Purpose:
Supportive Care
Official Title:
The Effect of Distant Reiki Application on Pain, Functional Status and Sleep Quality in Rheumatoid Arthritis Patients
Actual Study Start Date :
Nov 20, 2022
Anticipated Primary Completion Date :
Jun 20, 2023
Anticipated Study Completion Date :
Jul 20, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Distant reiki group

To examine the effect of distant reiki application on pain, functional status and sleep quality in rheumatoid arthritis patients.

Behavioral: Distant reiki group
ccording to Classical Usui Reiki, Reiki II. Remote Reiki will be practiced twice a week for 6 weeks by researchers who have completed the Phase 2 training. The time of remote reiki application will be planned by talking with the patient.

No Intervention: Control group

Control group; routine care and treatment will be applied.

Outcome Measures

Primary Outcome Measures

  1. Distant Reiki application changes the level of pain in rheumatoid arthritis patients. [6 weeks]

    Pain level will be assessed using the Visual Analog Scale as a pre-test before starting the distant reiki application and 6 weeks later as a post-test. (Distant Reiki will be applied for 30 minutes twice a week for 6 weeks).

  2. Distant Reiki application changes the functional status in rheumatoid arthritis patients. Health Assessment Survey will be used to evaluate the functional status of patients in rheumatic diseases. [6 weeks]

    Functional status will be assessed using the Health Assessment Survey as a pre-test and 6 weeks later as a post-test. (Distant Reiki will be applied for 30 minutes twice a week for 6 weeks).

  3. Distant Reiki application changes sleep quality in rheumatoid arthritis patients. Sleep quality will be assessed using the Pittsburgh Sleep Quality Index. [6 weeks]

    Sleep quality will be assessed using the Pittsburgh Sleep Quality Index as a pre- test and 6 weeks later as a post-test test. (Distant Reiki will be applied for 30 minutes twice a week for 6 weeks).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 90 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Being over 18 years old,

  • Not having a communication problem,

  • Receiving outpatient treatment from the clinic where the research was conducted,

  • To have the physical and cognitive competence to answer the data collection forms,

  • Not having received body-mind therapy (yoga, reiki, meditation, etc.) in the last six months,

Exclusion Criteria:
  • individuals who have done reiki therapy before

  • Being under 18 years old,

  • Hearing and speaking problems that prevent communication,

  • Participating in yoga, reiki, meditation practices in the last 6 months,

  • Individuals with cognitive and severe psychiatric problems who cannot answer the survey questions

Contacts and Locations

Locations

Site City State Country Postal Code
1 Cemile KÜTMEÇ YILMAZ Merkez Aksaray Turkey 68100
2 Aksaray University Health Science Faculty Aksaray Turkey 68100

Sponsors and Collaborators

  • Aksaray University Training and Research Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Cemile KÜTMEÇ YILMAZ, Principal Investigator, Aksaray University Training and Research Hospital
ClinicalTrials.gov Identifier:
NCT05861934
Other Study ID Numbers:
  • 2022/14-02
First Posted:
May 17, 2023
Last Update Posted:
May 17, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 17, 2023